TrialBMC cardiovascular disorders2018

Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial.

Wonjae Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.